MedTrace Logo

Evaluation of the Efficacy and Safety of Dallixa® Eyebrow Serum (Produced by Quantum Aesthetics Cosmetics, Turkey) in Subjects With Eyebrow Hypotrichosis

NCT07775989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2026-08-20

No results posted yet for this study

Summary

A Prospective, single arm, and interventional Clinical Trial

Conditions

  • Hypotrichosis

Interventions

OTHER

dermo cosmetic product

dermo cosmetic product like herbal or vitamin ingredients

Sponsors & Collaborators

  • Quantum Aesthetics Cosmetics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-28
Primary Completion
2026-04-20
Completion
2026-04-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07775989 on ClinicalTrials.gov